• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A political history of medicare and prescription drug coverage.医疗保险与处方药覆盖范围的政治史。
Milbank Q. 2004;82(2):283-354. doi: 10.1111/j.0887-378X.2004.00311.x.
2
Medicare program; Medicare prescription drug benefit. Final rule.医疗保险计划;医疗保险处方药福利。最终规则。
Fed Regist. 2005 Jan 28;70(18):4193-585.
3
Medicare reform--a wolf in sheep's clothing.医疗保险改革——披羊皮的狼。
J Aging Soc Policy. 2005;17(3):1-17. doi: 10.1300/J031v17n03_01.
4
Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.医疗保险D部分:2007年药剂师和受益人的若干问题
J Manag Care Pharm. 2007 Jan-Feb;13(1):59-65. doi: 10.18553/jmcp.2007.13.1.59.
5
Medicare and prescription drugs.医疗保险与处方药。
N Engl J Med. 2001 Mar 29;344(13):1010-5. doi: 10.1056/NEJM200103293441311.
6
Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.医疗保险计划;医疗保险处方药折扣卡。有意见征求期的暂行最终规则。
Fed Regist. 2003 Dec 15;68(240):69839-927.
7
Medicare program; establishment of the Medicare advantage program. Final rule.医疗保险计划;医疗保险优势计划的设立。最终规则。
Fed Regist. 2005 Jan 28;70(18):4587-741.
8
The new Medicare drug benefit: much ado about little?新的医疗保险药品福利:小题大做?
LDI Issue Brief. 2004 Jan-Feb;9(4):1-6.
9
Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.药品:《医疗保险现代化法案》——2005年。年终问题简报。
Issue Brief Health Policy Track Serv. 2005 Dec 31:1-21.
10
The Medicare prescription drug proposals and health insurance risk.
NHPF Issue Brief. 2003 Sep 4(793):1-12.

引用本文的文献

1
Negotiating Medicare Drug Prices: A New Attempt to Control Purchase Prices.协商医疗保险药品价格:控制采购价格的新尝试。
J Law Med Ethics. 2025 Apr 21;53(1):1-11. doi: 10.1017/jme.2025.59.
2
The Health Costs of Cost Sharing.成本分摊的健康成本。
Q J Econ. 2024 May 3;139(4):2037-2082. doi: 10.1093/qje/qjae015. eCollection 2024 Nov.
3
Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications.从胰岛素中吸取的教训:制定负担得起的糖尿病和肥胖症药物的政策处方。
Diabetes Care. 2024 Aug 1;47(8):1246-1256. doi: 10.2337/dci23-0042.
4
Pharmaceutical policies: effects of regulating drug insurance schemes.药品政策:规范药品保险计划的影响
Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2.
5
Subsidy Design in Privately Provided Social Insurance: Lessons from Medicare Part D.私人提供的社会保险中的补贴设计:来自医疗保险D部分的经验教训。
J Polit Econ. 2020 May;128(5):1712-1752. doi: 10.1086/705550. Epub 2020 Mar 18.
6
Who Pays in Medicare Part D? Giving Plans More Skin in the Game.医疗保险D部分由谁付费?让医保计划承担更多风险。
N Engl J Med. 2019 Dec 19;381(25):2384-2387. doi: 10.1056/NEJMp1912357. Epub 2019 Nov 20.
7
Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study.加拿大安大略省新增高费用老年患者的医疗利用增量和费用:一项回顾性匹配队列研究。
BMJ Open. 2019 Oct 28;9(10):e028637. doi: 10.1136/bmjopen-2018-028637.
8
Impact of Medicare Part D on Racial and Ethnic Minorities.医疗保险处方药福利计划(Medicare Part D)对少数族裔的影响。
Divers Equal Health Care. 2016;13(5):326-333. Epub 2016 Aug 23.
9
Caution is Needed in Designing Pharmacy Coverage.设计药房保险范围时需谨慎。
J Am Heart Assoc. 2016 Nov 11;5(11):e004466. doi: 10.1161/JAHA.116.004466.
10
Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.医疗保险D部分对药物使用和自付费用的影响:一项系统评价。
Health Serv Res. 2017 Oct;52(5):1685-1728. doi: 10.1111/1475-6773.12534. Epub 2016 Aug 1.

本文引用的文献

1
Employer-sponsored health insurance and prescription drug coverage for new retirees: dramatic declines in five years.
Health Aff (Millwood). 2003 Jul-Dec;Suppl Web Exclusives:W3-334-41. doi: 10.1377/hlthaff.w3.334.
2
Health spending rebound continues in 2002.2002年医疗支出继续反弹。
Health Aff (Millwood). 2004 Jan-Feb;23(1):147-59. doi: 10.1377/hlthaff.23.1.147.
3
Tracking health care costs: trends slow in first half of 2003.追踪医疗保健成本:2003年上半年趋势趋缓。
Data Bull (Cent Stud Health Syst Change). 2003 Dec(26):1-2.
4
Trends in Medicare supplemental insurance and prescription drug coverage, 1996-1999.1996 - 1999年医疗保险补充保险和处方药覆盖情况的趋势
Health Aff (Millwood). 2002 Jul-Dec;Suppl Web Exclusives:W127-38. doi: 10.1377/hlthaff.w2.127.
5
Defining health care reform. [Review of: Hacker, JS. The road to nowhere: the genesis of President Clinton's plan for health security. Princeton University Press, 1997].界定医疗保健改革。[评介:哈克,J.S.《无路可走:克林顿总统医疗保障计划的起源》。普林斯顿大学出版社,1997年]
Rev Am Hist. 1997 Sep;25(3):520-5.
6
National health expenditures, 1998.1998年国家卫生支出
Health Care Financ Rev. 1999 Winter;21(2):165-210.
7
Managing the pharmacy benefit in Medicare HMOs: what do we really know?
Health Aff (Millwood). 2000 Mar-Apr;19(2):42-58. doi: 10.1377/hlthaff.19.2.42.
8
Prescription drugs: issues of cost, coverage, and quality.处方药:成本、保险范围及质量问题。
EBRI Issue Brief. 1999 Apr(208):1-21.
9
Covering prescription drugs under Medicare: for the good of the patients.
Health Aff (Millwood). 1999 Jul-Aug;18(4):23-4. doi: 10.1377/hlthaff.18.4.23.
10
A drug benefit: the necessary prescription for Medicare.
Health Aff (Millwood). 1999 Jul-Aug;18(4):20-2. doi: 10.1377/hlthaff.18.4.20.

医疗保险与处方药覆盖范围的政治史。

A political history of medicare and prescription drug coverage.

作者信息

Oliver Thomas R, Lee Philip R, Lipton Helene L

机构信息

Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, 624 N. Broadway, Room 403, Baltimore, MD 21205-1999, USA.

出版信息

Milbank Q. 2004;82(2):283-354. doi: 10.1111/j.0887-378X.2004.00311.x.

DOI:10.1111/j.0887-378X.2004.00311.x
PMID:15225331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2690175/
Abstract

This article examines the history of efforts to add prescription drug coverage to the Medicare program. It identifies several important patterns in policymaking over four decades. First, prescription drug coverage has usually been tied to the fate of broader proposals for Medicare reform. Second, action has been hampered by divided government, federal budget deficits, and ideological conflict between those seeking to expand the traditional Medicare program and those preferring a greater role for private health care companies. Third, the provisions of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 reflect earlier missed opportunities. Policymakers concluded from past episodes that participation in the new program should be voluntary, with Medicare beneficiaries and taxpayers sharing the costs. They ignored lessons from past episodes, however, about the need to match expanded benefits with adequate mechanisms for cost containment. Based on several new circumstances in 2003, the article demonstrates why there was a historic opportunity to add a Medicare prescription drug benefit and identify challenges to implementing an effective policy.

摘要

本文考察了将处方药保险纳入医疗保险计划的努力历程。它识别了四十多年来政策制定中的几个重要模式。首先,处方药保险通常与更广泛的医疗保险改革提案的命运相关联。其次,政府分歧、联邦预算赤字以及寻求扩大传统医疗保险计划的人与倾向于让私人医疗保健公司发挥更大作用的人之间的意识形态冲突阻碍了行动。第三,2003年《医疗保险处方药、改进和现代化法案》的条款反映了早期错失的机会。政策制定者从过去的事件中得出结论,新计划的参与应该是自愿的,医疗保险受益人和纳税人分担成本。然而,他们忽视了过去事件中关于需要将扩大的福利与适当的成本控制机制相匹配的教训。基于2003年的几个新情况,本文阐述了为何存在增加医疗保险处方药福利的历史性机会,并确定了实施有效政策面临的挑战。